Skip to main content

Site notifications

CIPLA IPRATROPIUM (Cipla Australia Pty Ltd)

Product name
CIPLA IPRATROPIUM
Date registered
Evaluation commenced
Decision date
Approval time
154 (255 working days)
Active ingredients
ipratropium bromide monohydrate
Registration type
New generic medicine
Indication

[TRADE NAME] metered aerosol is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with asthma and chronic obstructive pulmonary disease (COPD).